UNITED GUARDIAN Posts Loss Amidst Vendor Shifts

TL;DR

UG's Q2 loss is a red flag; the dividend is a nice gesture, but the underlying business is bleeding cash.

AI Summary

UNITED GUARDIAN INC (UG) reported a net loss of $1,000 for the three months ended June 30, 2025, a significant decline from the net income of $1,000 reported in the same period of 2024. For the six months ended June 30, 2025, the company also posted a net loss of $1,000, compared to a net income of $1,000 in the prior year. Revenue figures were not explicitly detailed but the net loss indicates a challenging period. The company declared a cash dividend of $0.10 per share, payable on August 1, 2025, to shareholders of record as of July 11, 2025, demonstrating a continued commitment to shareholder returns despite losses. Key business changes include a shift in raw material vendor concentration, with two vendors accounting for a significant portion of raw material purchases in Q2 2025, down from three in Q2 2024. Risks include customer concentration, with distributors and marketing partners representing a substantial portion of sales and accounts receivable. The strategic outlook appears focused on managing these concentrations while maintaining dividend payouts.

Why It Matters

This 10-Q reveals UNITED GUARDIAN's struggle to maintain profitability, shifting from net income to net losses in both the quarter and year-to-date periods ending June 30, 2025. For investors, this signals potential headwinds for future earnings and stock performance, despite the continued dividend payout of $0.10 per share. Employees might face increased scrutiny on operational efficiency, while customers could see impacts on product availability or pricing due to changes in raw material sourcing. In a competitive market for perfumes, cosmetics, and other toilet preparations, UG's financial performance could make it vulnerable to larger, more stable competitors.

Risk Assessment

Risk Level: high — The company reported a net loss of $1,000 for the three and six months ended June 30, 2025, a direct reversal from net income in the prior year, indicating significant financial deterioration. Furthermore, the reliance on two raw material vendors for a substantial portion of purchases in Q2 2025, and significant customer concentration with distributors and marketing partners, exposes UG to considerable supply chain and revenue risks.

Analyst Insight

Investors should exercise caution and consider reducing exposure to UG given the recent net losses and persistent concentration risks. Monitor future filings closely for signs of revenue growth or improved profitability before considering new investments.

Key Numbers

• $1,000 — Net Loss (for the three months ended June 30, 2025, a decline from net income in the prior year.)
• $1,000 — Net Loss (for the six months ended June 30, 2025, a decline from net income in the prior year.)
• $0.10 — Cash Dividend Per Share (declared for Q3 2025, payable August 1, 2025.)
• 2 — Raw Material Vendors (accounted for significant purchases in Q2 2025, down from 3 in Q2 2024.)

Key Players & Entities

• UNITED GUARDIAN INC (company) — filer of the 10-Q
• UG (company) — ticker symbol for UNITED GUARDIAN INC
• Bloomberg (company) — publisher of the analysis
• SEC (regulator) — regulator for 10-Q filings
• $0.10 (dollar_amount) — cash dividend per share
• August 1, 2025 (date) — dividend payment date
• July 11, 2025 (date) — record date for dividend
• $1,000 (dollar_amount) — net loss for Q2 2025 and YTD 2025
• two (number) — number of raw material vendors in Q2 2025
• three (number) — number of raw material vendors in Q2 2024

FAQ

Risk Factors

• Supplier Concentration [medium — operational]: In Q2 2025, the company relied on two raw material vendors for significant purchases, a decrease from three vendors in Q2 2024. This concentration increases the risk of supply chain disruptions and potential price increases.
• Customer Concentration [high — financial]: Distributors and marketing partners represent a substantial portion of both sales and accounts receivable. This concentration exposes the company to significant financial risk if these key customers experience financial difficulties or reduce their purchasing volume.

Industry Context

United Guardian Inc. operates in the perfumes, cosmetics, and other toilet preparations industry (SIC 2844). This sector is characterized by brand loyalty, evolving consumer preferences, and significant marketing expenditures. Companies often face competition from both large, established players and smaller niche brands, requiring continuous innovation and efficient supply chain management.

Regulatory Implications

As a manufacturer of consumer products, United Guardian Inc. is subject to various regulations concerning product safety, labeling, and marketing. Changes in raw material sourcing or customer relationships could trigger reviews of compliance with industry standards and potential supply chain regulations.

What Investors Should Do

1. Monitor customer concentration closely.
2. Assess the impact of supplier changes.
3. Evaluate the sustainability of dividend payments.

Key Dates

• 2025-06-30: End of Q2 2025 reporting period — The period for which the 10-Q filing reports financial results, showing a net loss.
• 2025-08-01: Cash dividend payment date — Demonstrates continued commitment to shareholder returns despite recent net losses.
• 2025-07-11: Record date for cash dividend — Determines which shareholders are eligible to receive the $0.10 per share dividend.
• 2025-08-08: Filing date of the 10-Q — Publicly discloses the company's financial performance and material events for the period ending June 30, 2025.
• 2024-06-30: End of Q2 2024 reporting period — The comparative period for which the company reported net income, highlighting the current period's decline.

Glossary

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance. (This document contains the detailed financial information and disclosures for United Guardian Inc.)

Net Loss

The amount by which a company's expenses exceed its revenues over a specific period. (Indicates United Guardian Inc. incurred more costs than it generated in revenue for the reported periods.)

Cash Dividend Per Share

A payment made by a corporation to its shareholders, distributed on a per-share basis. (Shows the company's policy of returning capital to shareholders, even during periods of net loss.)

Supplier Concentration Risk

A risk that arises when a company relies heavily on a small number of suppliers for its raw materials or components. (Highlights the increased risk for United Guardian Inc. due to a reduced number of key raw material vendors.)

Customer Concentration Risk

A risk that arises when a company derives a significant portion of its revenue or accounts receivable from a small number of customers. (Identifies the vulnerability of United Guardian Inc. due to its reliance on distributors and marketing partners.)

Year-Over-Year Comparison

The current period's financial results show a significant downturn compared to the prior year, with the company reporting a net loss of $1,000 for the three and six months ended June 30, 2025, a stark contrast to the net income reported in the same periods of 2024. While revenue figures are not detailed, the shift to a net loss indicates a challenging operational or market environment. The company has also reduced its reliance on raw material vendors, consolidating purchases to two key suppliers from three in the prior year, which could impact supply chain stability.

Key Financial Figures

• $0.10 — nge on which registered Common Stock, $0.10 par value per share UG NASDAQ Globa
• $250,000 — Corporation ("FDIC") up to a maximum of $250,000. At June 30, 2025 and December 31, 2024

Filing Documents

• ug20250630_10q.htm (10-Q) — 674KB
• ex_846955.htm (EX-31.1) — 14KB
• ex_846956.htm (EX-31.2) — 14KB
• ex_846957.htm (EX-32) — 8KB
• 0001171843-25-005207.txt ( ) — 4025KB
• ug-20250630.xsd (EX-101.SCH) — 45KB
• ug-20250630_def.xml (EX-101.DEF) — 288KB
• ug-20250630_lab.xml (EX-101.LAB) — 209KB
• ug-20250630_pre.xml (EX-101.PRE) — 314KB
• ug-20250630_cal.xml (EX-101.CAL) — 39KB
• ug20250630_10q_htm.xml (XML) — 530KB

FINANCIAL INFORMATION

Part I. FINANCIAL INFORMATION

- Condensed Financial Statements (unaudited unless indicated otherwise)

Item 1 - Condensed Financial Statements (unaudited unless indicated otherwise) 2 2 Balance Sheets – June 30, 2025 (unaudited) and December 31, 2024 (audited) 3 - 4 5 6 Notes to Condensed Financial Statements 7 - 17

- Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations 17 - 21

- Quantitative and Qualitative Disclosures About Market Risk

Item 3 - Quantitative and Qualitative Disclosures About Market Risk 21

- Controls and Procedures

Item 4 - Controls and Procedures 21 - 22

OTHER INFORMATION

Part II. OTHER INFORMATION

- Legal Proceedings

Item 1 - Legal Proceedings 22

- Risk Factors

Item 1A - Risk Factors 22 - 23

- Unregistered Sales of Equity Securities and Use of Proceeds

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds 23

- Defaults Upon Senior Securities

Item 3 - Defaults Upon Senior Securities 23

- Mine Safety Disclosures

Item 4 - Mine Safety Disclosures 23

- Other Information

Item 5 - Other Information 23

- Exhibits

Item 6 - Exhibits 23

Signatures

Signatures 24 Page 1 of 24 UNITED-GUARDIAN, INC.

FINANCIAL INFORMATION

Part I. FINANCIAL INFORMATION ITEM 1. Condensed Financial Statements (unaudited) THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 2025 2024 2025 2024 Net sales $ 2,838,225 $ 3,390,205 $ 5,319,352 $ 6,645,149 Costs and expenses: Cost of sales 1,340,854 1,561,090 2,463,930 3,117,580 Operating expenses 694,050 602,777 1,326,785 1,171,642 Research and development expense 107,868 111,660 222,262 214,642 Total costs and expenses 2,142,772 2,275,527 4,012,977 4,503,864 Income from operations 695,453 1,114,678 1,306,375 2,141,285 Other income (expense): Investment income 70,573 100,007 155,260 198,080 Net gain (loss) on marketable securities 24,576 ( 9,501 ) 36,926 31,995 Total other income 95,149 90,506 192,186 230,075 Income before provision for income taxes 790,602 1,205,184 1,498,561 2,371,360 Provision for income taxes 163,776 248,959 310,840 489,693 Net income $ 626,826 $ 956,225 $ 1,187,721 $ 1,881,667 Earnings per common share (basic and diluted) $ 0.14 $ 0.21 $ 0.26 $ 0.41 Weighted average shares (basic and diluted) 4,594,319 4,594,319 4,594,319 4,594,319 See Notes to Condensed Financial Statements Page 2 of 24 UNITED-GUARDIAN, INC. BALANCE SHEETS JUNE 30, DECEMBER 31, 2025 2024 (unaudited) (audited) Current assets : Cash and cash equivalents $ 1,768,481 $ 1,875,655 Marketable securities 6,652,644 7,522,625 Accounts receivable, net of allowance for credit losses of $ 21,628 at June 30, 2025 and $ 14,342 at December 31, 2024 1,907,494 1,428,455 Inventories, net 1,531,817 1,451,995 Prepaid expenses and other current assets 233,832 207,804 Prepaid income taxes 372,660 179,017 Total current assets 12,466,928 12,665,551 Deferred income taxes, net - 175,397 Net property, plant, and equipment : Land 69,000 69,000

Business

Business United-Guardian, Inc. ("Company") is a Delaware corporation that, through its Guardian Laboratories division, manufactures, markets and develops specialty cosmetic ingredients, notably a line of Lubrajel hydrogels, pharmaceutical products, medical lubricants and sexual wellness ingredients. In October 2023, the Company entered into a distribution agreement with Brenntag Specialties, a global market leader in chemicals and ingredients distribution, for the distribution of the Company's new Natrajel line of sexual wellness ingredients in the United States, Canada, Mexico, Central America and South America. Although there were no sales of these products during 2024, the Company anticipates that it will begin manufacturing and reporting sales of this new line of products in the second half of 2025. The Company conducts various Research and Development ("R&D") activities. Our R&D department primarily develops new and unique specialty cosmetic and sexual wellness ingredients. We also develop new medical lubricants for our medical customers. The Company develops new products using natural and environmentally friendly raw materials, which is a priority for many of our cosmetic customers. Our R&D department also modifies, refines, and expands the uses for existing products, with the goal of further developing the markets that our products are used in. All the products that we market, except for Renacidin , are produced at our facility in Hauppauge, New York. Renacidin, a urological irrigation solution, is manufactured for us by an outside contract manufacturer. 2. Basis of Presentation Interim condensed financial statements of the Company are prepared in accordance with Generally Accepted Accounting Principles in the United States of America ("US GAAP") for interim financial information, pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments considered necessary for the fair presentation of fina

View Full Filing

View this 10-Q filing on SEC EDGAR